Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
about
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesEffect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials.The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary FibrosisVCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis.Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.Idiopathic pulmonary fibrosis: pathogenesis and management.
P2860
Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Treatment of pulmonary hyperte ...... l in efficacy or trial design?
@en
type
label
Treatment of pulmonary hyperte ...... l in efficacy or trial design?
@en
prefLabel
Treatment of pulmonary hyperte ...... l in efficacy or trial design?
@en
P2860
P31
P921
P356
P1476
Treatment of pulmonary hyperte ...... l in efficacy or trial design?
@en
P2093
Christopher S King
Steven D Nathan
P2860
P304
P356
10.2147/DDDT.S64907
P407
P5008
P577
2014-07-02T00:00:00Z